PLRX
Price:
$1.16
Market Cap:
$71.83M
Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States. Its flagship investigational product, PLN-74809, is an orally administered, small-molecule, dual-selective inhibitor targeting both avß6 and avß1 integrins, which is currently progressing through three distinct Phase 2a clinical trials. The company's pipeline also includes PLN-1474, a small-molecule selective inhibitor of avß1, which has successfully completed its Phase 1 clinical assessment for treating liver fibrosis associated with nonalcoholic steatohepatitis...[Read more]
Industry
Biotechnology
IPO Date
2020-06-03
Stock Exchange
NASDAQ
Ticker
PLRX
According to Pliant Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -59.06%. This represents a change of 307.69% compared to the average of -14.49% of the last 4 quarters.
The mean historical ROE of Pliant Therapeutics, Inc. over the last ten years is 296.96%. The current -59.06% ROE has changed -119.89% with respect to the historical average. Over the past ten years (40 quarters), PLRX's ROE was at its highest in in the March 2020 quarter at 6.35%. The ROE was at its lowest in in the December 2019 quarter at -9200.46%.
Average
296.96%
Median
-39.36%
Minimum
-616.50%
Maximum
3.43%
Discovering the peaks and valleys of Pliant Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 233.01%
Maximum Annual ROE = 3.43%
Minimum Annual Increase = -656.79%
Minimum Annual ROE = -616.50%
| Year | ROE | Change |
|---|---|---|
| 2025 | -82.42% | 19.17% |
| 2024 | -69.16% | 103.01% |
| 2023 | -34.07% | -13.44% |
| 2022 | -39.36% | -19.45% |
| 2021 | -48.86% | 233.01% |
| 2020 | -14.67% | -110.12% |
| 2019 | 145.06% | -95.77% |
| 2018 | 3.43% | -656.79% |
The current ROE of Pliant Therapeutics, Inc. (PLRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-61.88%
5-year avg
-54.77%
10-year avg
296.96%
Pliant Therapeutics, Inc.’s ROE is greater than Zentalis Pharmaceuticals, Inc. (-53.61%), less than Sutro Biopharma, Inc. (192.77%), greater than Artiva Biotherapeutics, Inc. (-73.16%), greater than Adverum Biotechnologies, Inc. (-3844.85%), less than Clene Inc. (233.93%), greater than MacroGenics, Inc. (-147.80%), greater than Whitehawk Therapeutics Inc (-79.63%), greater than Ovid Therapeutics Inc. (-22.51%), greater than Coya Therapeutics, Inc. (-57.26%), greater than Fractyl Health, Inc. Common Stock (-4573.89%),
| Company | ROE | Market cap |
|---|---|---|
| -53.61% | $263.39M | |
| 192.77% | $286.74M | |
| -73.16% | $242.72M | |
| -3844.85% | $96.26M | |
| 233.93% | $61.95M | |
| -147.80% | $262.52M | |
| -79.63% | $218.58M | |
| -22.51% | $299.38M | |
| -57.26% | $89.59M | |
| -4573.89% | $61.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pliant Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pliant Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pliant Therapeutics, Inc.'s ROE?
How is the ROE calculated for Pliant Therapeutics, Inc. (PLRX)?
What is the highest ROE for Pliant Therapeutics, Inc. (PLRX)?
What is the 3-year average ROE for Pliant Therapeutics, Inc. (PLRX)?
What is the 5-year average ROE for Pliant Therapeutics, Inc. (PLRX)?
How does the current ROE for Pliant Therapeutics, Inc. (PLRX) compare to its historical average?